StockData
Atrium Therapeutics, Inc. logo

Atrium Therapeutics, Inc. (RNA) stock

RNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$6.48+0.05 (+0.78%)

Close on Nov 17, 2026Market cap $110.85MP/E –Yield –

Atrium Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Atrium Therapeutics

Atrium Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Atrium Therapeutics figures

See a number that looks wrong?